Loss of Bladder Control Following Recurrent Infections
反复感染后膀胱失去控制
基本信息
- 批准号:10368136
- 负责人:
- 金额:$ 40.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-16 至 2024-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcuteAntibodiesAnxietyBack PainBacterial InfectionsBiological MarkersBladderBladder ControlBladder DysfunctionC FiberCellsClinical ResearchDefectDegenerative polyarthritisDetectionExhibitsExposure toFrequenciesGangliaGrowthGrowth FactorHyperactivityHyperplasiaImmuneImmune responseImmunologic MemoryImpairmentInfectionLinkMechanicsMediator of activation proteinMorbidity - disease rateMotorMusMuscle ContractionNatureNerveNerve FibersNerve Growth Factor ReceptorsNerve Growth FactorsNeuraxisNeuronsNociceptionOrganOutcomeOveractive BladderPainPelvisPropertyRecording of previous eventsRecurrenceRisk FactorsRoleSensorySeveritiesSourceTherapeuticUrinary tract infectionUrinationUrineUropathogenic E. coliWild Type Mouseafferent nerveantagonistcholinergicdensitydetrusor muscleexperiencemast cellmonocytemouse modelneurotransmissionneurotrophic factorpathogenpreclinical studypressurepreventpsychologicrecruitrecurrent infectionresponsespinal nerve posterior roottherapeutic targeturinary
项目摘要
Current estimates for the annual treatment of UTIs in the US including recurrences and their
complications exceed $3.5 billion. A significant number of UTIs are recurrent (recUTIs), with the
same subject experiencing multiple bouts of infection. A frequent outcome of recUTIs is loss in
bladder control which is manifested as increased urgency and frequency accompanied by loss
of bladder capacity. In spite of the severe discomfort and anxiety associated with this condition,
the underlying basis for bladder impairment has remained unresolved. In an experimental
mouse model of UPEC-induced recUTIs, we observed exuberant sprouting of sensory and
sympathetic nerves was observed in the mouse bladder, which closely paralleled increased
bladder frequency and reduced bladder capacity in the infected mice. These observations
suggest that bladder nerve fibers actively respond to bacterial infections and these responses
could potentially contribute to loss of bladder dysfunction. Since a known determinant of nerve
cells sprouting in the bladder is nerve growth factor (NGF) we looked for possible sources of this
growth factor. We have identified mast cells (MCs) and monocytes as putative cellular sources
of NGF as mice subjected to recUTIs contain large number of recruited monocytes compared to
naïve mice and MC deficient mice do not any loss of bladder control even after recUTIs.
Therefore, we hypothesize that the loss of bladder control after recUTIs, is the direct result of
nerve fiber hyperplasia which is induced by NGF and other neurotrophic factors produced by
local MCs and MC recruited monocytes. We further hypothesize that it is possible to prevent
loss of bladder control in mice subjected to recUTIs by therapeutic targeting of NGF and other
neurotrophic factors. To validate these notions, we have proposed the following specific aims: (i)
Establish a clear link between neuronal sprouting and loss of bladder control in mice subjected
to recUTIs;; (iii) Examine the role of neurotrophic factors in bladder dysfunction following recUTIs
and the effect of targeting these factors to protect and even reverse bladder dysfunction (iii)
Investigate the contribution of MCs to neuronal sprouting and bladder impairment.
目前对美国尿路感染年度治疗的估计,包括复发率及其发生情况
并发症价值超过 35 亿美元,大量尿路感染是复发性 (recUTI),其中
同一受试者进行多次感染实验,recUTIs 的一个常见结果是损失。
膀胱控制,表现为尿急和尿频增加,并伴有尿失禁。
尽管与这种情况相关的严重不适和焦虑,
在一项实验中,膀胱损伤的根本原因仍未解决。
UPEC 诱导的 recUTI 小鼠模型中,我们观察到感觉和神经细胞的旺盛萌芽
在小鼠膀胱中观察到交感神经,这与增加的交感神经密切相关
受感染小鼠的膀胱频率和膀胱容量减少。
表明膀胱神经纤维对细菌感染做出积极反应,并且这些反应
由于已知的神经决定因素,可能会导致膀胱功能障碍的丧失。
膀胱中发芽的细胞是神经生长因子(NGF),我们寻找其可能的来源
我们已确定肥大细胞 (MC) 和单核细胞为假定的细胞来源。
与接受 recUTI 的小鼠相比,NGF 含有大量招募的单核细胞
幼稚小鼠和 MC 缺陷小鼠即使在复发性尿路感染后也不会丧失膀胱控制。
因此,我们假设,recUTI 后膀胱失控是以下因素的直接结果:
神经纤维增生是由NGF和其他神经营养因子产生的
我们进一步假设可以预防局部 MC 和 MC 募集的单核细胞。
通过 NGF 和其他药物的治疗靶向,导致患有 recUTI 的小鼠膀胱失去控制
神经营养因子。为了验证这些概念,我们提出了以下具体目标:(i)
在小鼠中建立神经元出芽和膀胱控制丧失之间的明确联系
recUTI;;(iii)检查神经营养因子在 recUTI 后膀胱功能障碍中的作用
以及针对这些因素保护甚至逆转膀胱功能障碍的效果 (iii)
研究 MC 对神经元出芽和膀胱损伤的贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Soman N Abraham其他文献
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines
Mastoparan-7 佐剂 COBRA H1 和 H3 血凝素流感疫苗
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:4.6
- 作者:
Pedro L Sanchez;H. Staats;Soman N Abraham;Ted M. Ross - 通讯作者:
Ted M. Ross
Soman N Abraham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Soman N Abraham', 18)}}的其他基金
A novel vaccination strategy to curb recUTIs
遏制复发尿路感染的新型疫苗接种策略
- 批准号:
10665990 - 财政年份:2023
- 资助金额:
$ 40.98万 - 项目类别:
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.
血小板-肥大细胞相互作用作为败血性休克血管病理学的决定因素。
- 批准号:
10343476 - 财政年份:2021
- 资助金额:
$ 40.98万 - 项目类别:
Loss of Bladder Control Following Recurrent Infections
反复感染后膀胱失去控制
- 批准号:
10612716 - 财政年份:2020
- 资助金额:
$ 40.98万 - 项目类别:
Aberrant remodeling of bladder following infection
感染后膀胱异常重塑
- 批准号:
10381529 - 财政年份:2019
- 资助金额:
$ 40.98万 - 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
- 批准号:
8668381 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
- 批准号:
9043871 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
- 批准号:
8908009 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Immune mediated exocytosis of intravesicular UPEC from bladder cells
免疫介导的膀胱细胞囊内 UPEC 胞吐作用
- 批准号:
9265085 - 财政年份:2014
- 资助金额:
$ 40.98万 - 项目类别:
Mast Cells in Dengue Pathology and Prevention
肥大细胞在登革热病理学和预防中的作用
- 批准号:
8680362 - 财政年份:2013
- 资助金额:
$ 40.98万 - 项目类别:
相似国自然基金
腺相关病毒载体介导的circ_12952基因治疗通过激活结直肠癌抗肿瘤免疫增强PD-1抗体疗效的机制研究及临床探索
- 批准号:82303073
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
聚合物囊泡靶向骨组织递送mRNA编码抗骨硬化蛋白单链抗体治疗骨质疏松的研究
- 批准号:82372442
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于抗原抗体相互作用的抗体定向虚拟设计与筛选
- 批准号:32370697
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CDK4/6抑制剂通过IFN/JAK/STAT1信号轴增强PD-1抗体抗肝细胞癌疗效的机制研究
- 批准号:82373313
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Development of a novel disease-modifying glycan therapeutic for early at-home intervention of acute vaso-occlusive crisis in sickle cell disease
开发一种新型疾病缓解聚糖疗法,用于镰状细胞病急性血管闭塞危象的早期家庭干预
- 批准号:
10603870 - 财政年份:2023
- 资助金额:
$ 40.98万 - 项目类别:
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)
推进化疗引起的周围神经病变 (CIPN) 的新型免疫疗法的发展
- 批准号:
10588384 - 财政年份:2023
- 资助金额:
$ 40.98万 - 项目类别:
COVID-19, Inflammation and HPA axis activity, and Risk for Psychopathology in Youth
COVID-19、炎症和 HPA 轴活动以及青少年精神病理学风险
- 批准号:
10753189 - 财政年份:2023
- 资助金额:
$ 40.98万 - 项目类别:
Novel tool development for quantitative PharmacoSTORM super-resolution imaging of the nanoscale distribution of D3 dopamine receptors
用于 D3 多巴胺受体纳米级分布定量 PharmacoSTORM 超分辨率成像的新工具开发
- 批准号:
10670438 - 财政年份:2022
- 资助金额:
$ 40.98万 - 项目类别:
Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD
老化 T 细胞衍生的细胞因子影响脑膜淋巴管并导致 AD
- 批准号:
10684836 - 财政年份:2022
- 资助金额:
$ 40.98万 - 项目类别: